BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//XIMA Media GmbH//xima_typo3_calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:entry-303@www.dkfz.de
DTSTAMP:20260929T145044Z
DTSTART:20250402T113000Z
DTEND:20250402T120000Z
SUMMARY:Meyenburg Symposium and Cancer Research Award Presentation to Miche
 l Sadelain
DESCRIPTION:Dear colleagues\, We are excited to invite you to this year’s
  Meyenburg Cancer Research Award ceremony\, honoring Dr. Michel Sadelain\,
  a visionary who transformed patients’ cells into “living drugs” tha
 t fight cancer. Dr. Sadelain’s groundbreaking work on chimeric antigen r
 eceptor (CAR) T-cell therapy has fundamentally changed how we treat certai
 n cancers. From the initial concept to FDA approval in 2017\, his journey 
 represents one of the most significant breakthroughs in modern oncology 
 – giving hope to patients who previously had none. (See below for more i
 nformation about Michel Sadelain and his work.) Please join us for the Mey
 enburg Symposium and Award Ceremony at the German Cancer Research Center (
 DKFZ) in Heidelberg on April 2\, 2025 at 3:30 p.m. Speakers include: • M
 ichel Sadelain • Andreas Mackensen (Erlangen University Hospital) • Fa
 brice André (Institut Gustave Roussy) • Hafsa Munir (DKFZ & Helmholtz I
 nstitute for Translational Oncology Mainz) • Franziska Blaeschke (DKFZ &
  Hopp Children's Cancer Center Heidelberg) Details of the program and regi
 stration (until March 28) can be found here: https://indico.dkfz.de/e/Meye
 nburgCancerResearchAward2025 We look forward to your participation. Very b
 est wishes\, Stefan Fröhling On behalf of the Board of the Meyenburg Foun
 dation Dr. Marion Meyenburg Dr. Jörg Barth\, Boehringer Ingelheim Prof. C
 hristiane Opitz\, DKFZ Prof. Stefan Pfister\, DKFZ About Michel Sadelain: 
 Revolutionary Science Meets Clinical Impact – Celebrating a Pioneer in C
 ancer Immunotherapy Dr. Sadelain received his M.D. from the University of 
 Paris\, conducted his Ph.D. research at the University of Alberta\, and co
 mpleted postdoctoral work at the Whitehead Institute for Biomedical Resear
 ch. He previously held the Stephen and Barbara Friedman Chair at Memorial 
 Sloan Kettering Cancer Center\, where he founded the Center for Cell Engin
 eering. As the inaugural Director of Columbia University’s Initiative in
  Cell Engineering and Therapy and the Columbia University Irving Medical C
 enter’s Cancer Cell Therapy Initiative\, Dr. Sadelain continues to push 
 boundaries in cellular engineering. Dr. Sadelain’s remarkable contributi
 ons have been recognized with prestigious accolades\, including the Breakt
 hrough Prize for Life Sciences and the Canada Gairdner International Award
 . He is a member of the American Academy of Arts and Sciences and the Nati
 onal Academy of Medicine of France. With the Meyenburg Cancer Research Awa
 rd\, we recognize Dr. Sadelain’s outstanding efforts to improve the clin
 ical care of cancer patients through scientific inquiry\, as well as his e
 ngaging and collaborative personality.
LOCATION:DKFZ Communication Center\, Lecture Hall
URL:https://www.dkfz.de/aktuelles/veranstaltungen/detail/53-meyenburg-sympo
 sium-and-cancer-research-award-presentation-to-michel-sadelain/a303
CATEGORIES:Sonstiges
ORGANIZER;CN="Anke Retzmann":mailto:a.retzmann@dkfz-heidelberg.de
STATUS:CONFIRMED
SEQUENCE:1790690401
LAST-MODIFIED:20260929T140001Z
END:VEVENT
END:VCALENDAR